Based on the provided data, here's a concise analysis of CRS's valuation:
Valuation Analysis: CRS currently trades at a P/E of 32.01, significantly higher than its historical average, suggesting stretched valuation levels. The EV/EBITDA ratio of 15.31 also indicates premium pricing compared to industry standards.
Recent Performance: The stock has shown remarkable strength, rallying 209.7% over the past year, significantly outperforming both its industry peers and the broader market.
Analyst Consensus: Recent analyst coverage remains predominantly bullish, with JP Morgan initiating coverage with a $220 price target, citing strong demand and solid execution. The consensus price target range is between $165-$220, suggesting limited upside from current levels.
Business Fundamentals: Q2 FY2025 results exceeded expectations with EPS of $1.66 vs $1.61 consensus, demonstrating strong execution but potentially already priced into the current valuation.
The stock appears overvalued at current levels based on traditional metrics, elevated multiples, and significant price appreciation already captured in the share price.